title: Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release.
abstract: Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.
authors.affiliation: Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, 1304 West Green Street, Urbana, IL 61801, USA. jianjunc@illinois.edu.
authors.forename: Hua
authors.initials: H
authors.lastname: Wang
authors.forename: Ming
authors.initials: M
authors.lastname: Xu
authors.forename: Menghua
authors.initials: M
authors.lastname: Xiong
authors.forename: Jianjun
authors.initials: J
authors.lastname: Cheng
mesh_terms: D000970:Antineoplastic Agents; D002166:Camptothecin / Q000737:chemistry*; D065546:Drug Liberation; D031541:Fluorescence Resonance Energy Transfer; D008301:Maleimides / Q000737:chemistry*; D008958:Models, Molecular; D015394:Molecular Structure; D036103:Nanotechnology
chemical_list: D000970:Antineoplastic Agents; D008301:Maleimides; D002166:Camptothecin